Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Wei-Qiang Gan"'
Publikováno v:
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-7 (2020)
BMC Infectious Diseases
BMC Infectious Diseases
Background Evaluate the safety and efficacy of 104-week regimen of Telbivudine(LdT)-based optimization strategy for Chinese patients who have chronic hepatits B(CHB) with HBeAg-negative. Methods This multi-center, open-label, prospective study enroll
Background: We encourage Hepatitis B virus-infected mothers to breastfeed postpartum, even when continuing pregnancy category B nucleos(t)ide analogs treatment. However, a large proportion of the Hepatitis B virus-infected mothers were not compliance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef0abb3d2e77990813ce0c90df6b692e
https://doi.org/10.21203/rs.3.rs-143445/v1
https://doi.org/10.21203/rs.3.rs-143445/v1
Autor:
Zhishuo Mo, Zhiliang Gao, Shi-Lei Xu, Lei Tan, Ze-Qian Wu, Wei-Qiang Gan, Jie-Huan Chen, Jian-Rong Liu
Publikováno v:
Ann Transl Med
BACKGROUND: While serum hepatitis B surface antigens (HBsAg) play an important role in the diagnosis and assessment of treatment results of hepatitis B virus (HBV) infections, it remains unclear whether HBsAg levels normalized to hepatic parenchymal
Autor:
Dong-Ying Xie, Zhishuo Mo, Qiyi Zhao, Zhiliang Gao, Wei-Qiang Gan, Dabiao Chen, Lei Tan, Ze-Qian Wu, Peipei Wang
Publikováno v:
Ann Transl Med
BACKGROUND: The seroconversion of the hepatitis B antigen is the ideal outcome for long-acting interferon-pegylated interferon-α (Peg-IFN-α) treatment among patients with chronic hepatitis B (CHB). B-cell response plays an important role in the pro
Publikováno v:
Hepatobiliary & Pancreatic Diseases International. 12:154-159
Selection of drugs for antiviral therapy of patients with hepatitis B virus (HBV)-related acute-on-chronic liver failure (ACLF) remains difficult. This study was undertaken to evaluate the short-term efficacy of entecavir versus lamivudine on hepatit
Autor:
Jing Liu, Yu-Bao Zheng, Zhi-liang Gao, Chao-shuang Lin, Wei-Qiang Gan, Zhe-Bin Wu, Zhi-xin Zhao
Publikováno v:
Experimental and Therapeutic Medicine. 3:1062-1066
The aim of this study was to evaluate the effect of pegylated interferon α-2a plus ribavirin therapy on the quality of life (QOL) of chronic hepatitis C patients when this treatment was paid for by healthcare insurance. The QOL questionnaire (GQOLI-
Publikováno v:
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology. 20(7)
To investigate the dynamics and clinical significance of serum hepatitis B virus (HBV) DNA levels during the terminal phase of acute-on-chronic liver failure (ACLF) with different hepatitis B e antigen (HBeAg) status.One-hundred-and-seven patients wi